James Mims, MD
Otolaryngology · Winston Salem, NCNPI 1194709576
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,693 of the $15,151 with a category attached, or 90.4%. Sanofi accounts for 64.6% of it on its own, with 6 other manufacturers making up the rest. Among otolaryngology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $1165.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$10K
- AstraZeneca$3K
- Regeneron$2K
- Acera Surgical, Inc.$90
- Inspire Medical Systems, Inc.$81
- Acclarent, Inc$14
- plus $3 from 1 others
Across 223 payments — averaging $461.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$98K
- GSK$4K
What the payments were for
- Consulting fees$13,69390%
- Speaking & faculty fees$1,2508%
- Food & beverage$2081%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 7 | $9,782 |
| AstraZeneca | 1 | $2,685 |
| Regeneron | 1 | $2,496 |
| Acera Surgical, Inc. | 1 | $90 |
| Inspire Medical Systems, Inc. | 1 | $81 |
| Acclarent, Inc | 1 | $14 |
| Forte Bio-pharma LLC | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,151 in reported general payments places this provider in the 95th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 20 | $528 |
| Azithromycin | 11 | $376 |
| Doxycycline Hyclate | 13 | $170 |
| Sodium ChlorideSodium Chloride Irrig Solution | 14 | $152 |
| Mupirocin | 24 | $130 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Winston Salem
- Adam CampbellWinston Salem$47K
- William ScurryWinston Salem$19K
- John BrittWinston Salem$4K
- Thomas FitzpatrickWinston Salem$4K
- David JangDurham$324K
- Robert FerrisRaleigh$258K
- Adam ZanationHickory$227K
- Brent SeniorChapel Hill$91K
- Charles EbertChapel Hill$57K
- Harold PillsburyChapel Hill$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.